• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA 模式在肾细胞癌和非肿瘤组织中的差异表达。

Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues.

机构信息

Department of Laboratory Medicine of Clinical Faculty, Weifang Medical University, Weifang, China.

出版信息

J Cancer Res Clin Oncol. 2010 Jun;136(6):855-62. doi: 10.1007/s00432-009-0726-x. Epub 2009 Nov 17.

DOI:10.1007/s00432-009-0726-x
PMID:19921256
Abstract

INTRODUCTION

MiRNAs are short single stranded RNAs that are associated with gene regulation at the transcriptional and translational level. Changes in their expression were found in a variety of human cancers. In the present study, we aimed to investigate expression profiles of miRNA (miRNA) in the clear cell subtype of kidney cancer and to develop further understanding of the molecular mechanisms involved in the pathogenesis of renal cell carcinoma.

MATERIALS AND METHODS

We analyzed the miRNA expression profiles in 30 pairs of renal cell carcinoma and adjacent nontumorous tissue (NT), using a mammalian miRNA microarray containing whole human mature and precursor miRNA sequences. Real-time quantitative PCR was performed to confirm the array results.

RESULTS

The miRNA microarray chip analysis identified 86 miRNAs differentially expressed in renal cell carcinoma tissues and a total of 38 miRNAs exhibited higher expression in the renal cell carcinoma samples than that in the NT samples, while 48 miRNA demonstrated lower expression in the renal cell carcinoma samples than that in the NT samples.

CONCLUSION

Quantitative real-time PCR analysis confirmed microarray data. The report supports that many miRNA expressions were altered in renal carcinoma, whose expression profiling may provide a useful clue for the pathophysiology research. However, further longer-term researches are required to investigate the relationship between miRNA and renal carcinoma as well as their role in carcinogenesis.

摘要

简介

miRNAs 是短链单链 RNA,与转录和翻译水平的基因调控有关。在各种人类癌症中都发现了它们表达的变化。在本研究中,我们旨在研究肾脏透明细胞癌中 miRNA(miRNA)的表达谱,并进一步了解肾癌发病机制中涉及的分子机制。

材料与方法

我们使用包含全人类成熟和前体 miRNA 序列的哺乳动物 miRNA 微阵列,分析了 30 对肾细胞癌和相邻非肿瘤组织(NT)中的 miRNA 表达谱。通过实时定量 PCR 验证了阵列结果。

结果

miRNA 微阵列芯片分析鉴定了 86 个在肾细胞癌组织中差异表达的 miRNA,共有 38 个 miRNA 在肾细胞癌样本中的表达高于 NT 样本,而 48 个 miRNA 在肾细胞癌样本中的表达低于 NT 样本。

结论

实时定量 PCR 分析证实了微阵列数据。该报告支持许多 miRNA 在肾癌中表达发生改变,其表达谱可能为病理生理学研究提供有用线索。然而,需要进一步进行更长期的研究来调查 miRNA 与肾癌之间的关系及其在致癌作用中的作用。

相似文献

1
Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues.miRNA 模式在肾细胞癌和非肿瘤组织中的差异表达。
J Cancer Res Clin Oncol. 2010 Jun;136(6):855-62. doi: 10.1007/s00432-009-0726-x. Epub 2009 Nov 17.
2
A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma.一种肿瘤特异性微小RNA特征可预测透明细胞肾细胞癌的生存率。
J Cancer Res Clin Oncol. 2015 Jul;141(7):1291-9. doi: 10.1007/s00432-015-1927-0. Epub 2015 Jan 30.
3
miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.miR-145 在肾细胞癌中作为肿瘤抑制因子发挥作用,靶向两个癌基因,ANGPT2 和 NEDD9。
J Cancer Res Clin Oncol. 2014 Mar;140(3):387-97. doi: 10.1007/s00432-013-1577-z. Epub 2014 Jan 3.
4
Potential prognostic value of miRNAs as biomarker for progression and recurrence after nephrectomy in renal cell carcinoma: a literature review.miRNAs 作为肾细胞癌肾切除术后进展和复发的潜在预后标志物的价值:文献综述。
Diagnosis (Berl). 2021 Oct 22;9(2):157-165. doi: 10.1515/dx-2021-0080.
5
MicroRNAs as biomarkers in spontaneous intracerebral hemorrhage: A systematic review of recent clinical evidence.微小 RNA 作为自发性脑出血的生物标志物:近期临床证据的系统评价。
Clin Neurol Neurosurg. 2022 Feb;213:107130. doi: 10.1016/j.clineuro.2022.107130. Epub 2022 Jan 14.
6
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.儿童癌症潜在肾毒性治疗后的早期和晚期肾脏不良反应。
Cochrane Database Syst Rev. 2013 Oct 8(10):CD008944. doi: 10.1002/14651858.CD008944.pub2.
7
Tumor Suppressor miRNA-based Signatures in Triple Negative Breast Cancer: A Study Based on Big Data Analysis of Gene Expression Omnibus (GEO) Datasets and Its Validation.三阴性乳腺癌中基于肿瘤抑制miRNA的特征:一项基于基因表达综合数据库(GEO)数据集大数据分析及其验证的研究
Asian Pac J Cancer Prev. 2025 Jun 1;26(6):2087-2095. doi: 10.31557/APJCP.2025.26.6.2087.
8
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.仑伐替尼联合帕博利珠单抗治疗未经治疗的晚期肾细胞癌:系统评价和成本效果分析。
Health Technol Assess. 2024 Aug;28(49):1-190. doi: 10.3310/TRRM4238.
9
Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.基于微阵列技术鉴定含CUB结构域蛋白1作为传统肾细胞癌潜在的预后标志物
J Cancer Res Clin Oncol. 2008 Dec;134(12):1363-9. doi: 10.1007/s00432-008-0412-4. Epub 2008 May 16.
10
Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.部分肾切除术与根治性肾切除术治疗 T1b 和 T2 期临床肾肿瘤的比较:系统评价和荟萃分析。
Eur Urol. 2017 Apr;71(4):606-617. doi: 10.1016/j.eururo.2016.08.060. Epub 2016 Sep 7.

引用本文的文献

1
The expression of apolipoproteina1 and its correlation with infiltration of urologic neoplasm.载脂蛋白A1的表达及其与泌尿系统肿瘤浸润的相关性。
Transl Cancer Res. 2020 Feb;9(2):690-697. doi: 10.21037/tcr.2019.11.51.
2
miR-129-5p inhibits clear cell renal cell carcinoma cell proliferation, migration and invasion by targeting SPN.微小RNA-129-5p通过靶向丝氨酸蛋白酶抑制剂(SPN)抑制肾透明细胞癌细胞的增殖、迁移和侵袭。
Cancer Cell Int. 2021 May 17;21(1):263. doi: 10.1186/s12935-021-01820-3.
3
miR-638 acts as an oncogene and predicts poor prognosis in renal cell carcinoma.

本文引用的文献

1
microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.微小RNA-451调节巨噬细胞移动抑制因子的产生及胃肠道癌细胞的增殖。
Clin Cancer Res. 2009 Apr 1;15(7):2281-90. doi: 10.1158/1078-0432.CCR-08-1818. Epub 2009 Mar 24.
2
MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets.微小RNA与肺癌:新的癌基因和肿瘤抑制因子、新的预后因素及潜在治疗靶点。
Curr Med Chem. 2009;16(9):1047-61. doi: 10.2174/092986709787581833.
3
Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells.
微小RNA-638作为一种癌基因,可预测肾细胞癌的不良预后。
Am J Transl Res. 2020 Jul 15;12(7):3645-3659. eCollection 2020.
4
Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.血清 microRNA,局部区域进展期鼻咽癌患者调强放疗后潜在的预后标志物。
BMC Cancer. 2020 Mar 4;20(1):183. doi: 10.1186/s12885-020-6689-7.
5
Knockdown of miR-572 suppresses cell proliferation and promotes apoptosis in renal cell carcinoma cells by targeting the NF2/Hippo signaling pathway.敲低miR-572可通过靶向NF2/ Hippo信号通路抑制肾癌细胞的增殖并促进其凋亡。
Int J Clin Exp Pathol. 2018 Dec 1;11(12):5705-5714. eCollection 2018.
6
Up-regulation of microRNA-200c-3p inhibits invasion and migration of renal cell carcinoma cells via the SOX2-dependent Wnt/β-catenin signaling pathway.微小RNA-200c-3p的上调通过SOX2依赖的Wnt/β-连环蛋白信号通路抑制肾癌细胞的侵袭和迁移。
Cancer Cell Int. 2019 Sep 7;19:231. doi: 10.1186/s12935-019-0944-5. eCollection 2019.
7
Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma.miR-381 抑制促进肾透明细胞癌细胞生长和化疗耐药性。
Med Sci Monit. 2019 Jul 12;25:5181-5190. doi: 10.12659/MSM.915524.
8
The potential role of miR-126, miR-21 and miR-10b as prognostic biomarkers in renal cell carcinoma.miR-126、miR-21和miR-10b作为肾细胞癌预后生物标志物的潜在作用。
Oncol Lett. 2019 May;17(5):4566-4574. doi: 10.3892/ol.2019.10142. Epub 2019 Mar 12.
9
Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells.上调的 microRNA-193a-3p 是 CD44(+)胃癌细胞顺铂耐药的原因。
Cancer Sci. 2019 Feb;110(2):662-673. doi: 10.1111/cas.13894. Epub 2018 Dec 26.
10
miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3.miR-122 通过抑制叉头框蛋白 O3 促进透明细胞肾细胞癌的增殖和侵袭。
Int J Oncol. 2019 Feb;54(2):559-571. doi: 10.3892/ijo.2018.4636. Epub 2018 Nov 19.
没食子酸表没食子儿茶素酯上调 miR-16 并诱导人癌细胞凋亡。
J Nutr Biochem. 2010 Feb;21(2):140-6. doi: 10.1016/j.jnutbio.2008.12.003. Epub 2009 Mar 9.
4
Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation.两个新的miR-16靶标:caprin-1和HMGA1,这两种蛋白质与细胞增殖有关。
Biol Cell. 2009 Sep;101(9):511-24. doi: 10.1042/BC20080213.
5
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.透明细胞肾细胞癌的 microRNA 谱分析确定了一个稳健的特征,以定义肾脏恶性肿瘤。
J Cell Mol Med. 2009 Sep;13(9B):3918-28. doi: 10.1111/j.1582-4934.2009.00705.x. Epub 2009 Feb 17.
6
Altered microRNA expression in patients with non-obstructive azoospermia.非梗阻性无精子症患者中微小RNA表达的改变。
Reprod Biol Endocrinol. 2009 Feb 11;7:13. doi: 10.1186/1477-7827-7-13.
7
Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.肾细胞癌全基因组微小RNA表达谱分析:miR-141和miR-200c显著下调
J Pathol. 2008 Dec;216(4):418-27. doi: 10.1002/path.2437.
8
Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients.系统性红斑狼疮患者外周血细胞中微小RNA表达的微阵列分析。
Lupus. 2007;16(12):939-46. doi: 10.1177/0961203307084158.
9
miRBase: tools for microRNA genomics.miRBase:用于微小RNA基因组学的工具。
Nucleic Acids Res. 2008 Jan;36(Database issue):D154-8. doi: 10.1093/nar/gkm952. Epub 2007 Nov 8.
10
Widespread deregulation of microRNA expression in human prostate cancer.人类前列腺癌中微小RNA表达的广泛失调。
Oncogene. 2008 Mar 13;27(12):1788-93. doi: 10.1038/sj.onc.1210809. Epub 2007 Sep 24.